R35GM122473
Project Grant
Overview
Grant Description
Chemistry principles applied to the development of new catalytic C-H bond functionalization methods for amine and heterocycle preparation and to the design, synthesis and use of new enzyme inhibitors.
CHEMISTRY PRINCIPLES APPLIED TO THE DEVELOPMENT OF NEW CATALYTIC C-H BOND FUNCTIONALIZATION METHODS FOR AMINE AND HETEROCYCLE PREPARATION AND TO THE DESIGN, SYNTHESIS AND USE OF NEW ENZYME INHIBITORS.
CHEMISTRY PRINCIPLES APPLIED TO THE DEVELOPMENT OF NEW CATALYTIC C-H BOND FUNCTIONALIZATION METHODS FOR AMINE AND HETEROCYCLE PREPARATION AND TO THE DESIGN, SYNTHESIS AND USE OF NEW ENZYME INHIBITORS.
Awardee
Funding Goals
THE NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES (NIGMS) SUPPORTS BASIC RESEARCH THAT INCREASES OUR UNDERSTANDING OF BIOLOGICAL PROCESSES AND LAYS THE FOUNDATION FOR ADVANCES IN DISEASE DIAGNOSIS, TREATMENT, AND PREVENTION. NIGMS ALSO SUPPORTS RESEARCH IN SPECIFIC CLINICAL AREAS THAT AFFECT MULTIPLE ORGAN SYSTEMS: ANESTHESIOLOGY AND PERI-OPERATIVE PAIN, CLINICAL PHARMACOLOGY ?COMMON TO MULTIPLE DRUGS AND TREATMENTS, AND INJURY, CRITICAL ILLNESS, SEPSIS, AND WOUND HEALING.? NIGMS-FUNDED SCIENTISTS INVESTIGATE HOW LIVING SYSTEMS WORK AT A RANGE OF LEVELSFROM MOLECULES AND CELLS TO TISSUES AND ORGANSIN RESEARCH ORGANISMS, HUMANS, AND POPULATIONS. ADDITIONALLY, TO ENSURE THE VITALITY AND CONTINUED PRODUCTIVITY OF THE RESEARCH ENTERPRISE, NIGMS PROVIDES LEADERSHIP IN SUPPORTING THE TRAINING OF THE NEXT GENERATION OF SCIENTISTS, ENHANCING THE DIVERSITY OF THE SCIENTIFIC WORKFORCE, AND DEVELOPING RESEARCH CAPACITY THROUGHOUT THE COUNTRY.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New Haven,
Connecticut
06511
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 04/30/22 to 04/30/27 and the total obligations have increased 1314% from $484,233 to $6,845,559.
Yale Univ was awarded
Chemistry for Catalytic C-H Bond Functionalization & Enzyme Inhibitors
Project Grant R35GM122473
worth $6,845,559
from the National Institute of General Medical Sciences in May 2017 with work to be completed primarily in New Haven Connecticut United States.
The grant
has a duration of 10 years and
was awarded through assistance program 93.859 Biomedical Research and Research Training.
The Project Grant was awarded through grant opportunity Maximizing Investigators' Research Award (R35 - Clinical Trial Optional).
Status
(Ongoing)
Last Modified 4/21/25
Period of Performance
5/1/17
Start Date
4/30/27
End Date
Funding Split
$6.8M
Federal Obligation
$0.0
Non-Federal Obligation
$6.8M
Total Obligated
Activity Timeline
Transaction History
Modifications to R35GM122473
Additional Detail
Award ID FAIN
R35GM122473
SAI Number
R35GM122473-3650856543
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NS00 NIH National Institute of General Medical Sciences
Funding Office
75NS00 NIH National Institute of General Medical Sciences
Awardee UEI
FL6GV84CKN57
Awardee CAGE
4B992
Performance District
CT-03
Senators
Richard Blumenthal
Christopher Murphy
Christopher Murphy
Budget Funding
Federal Account | Budget Subfunction | Object Class | Total | Percentage |
---|---|---|---|---|
National Institute of General Medical Sciences, National Institutes of Health, Health and Human Services (075-0851) | Health research and training | Grants, subsidies, and contributions (41.0) | $6,528,130 | 100% |
Modified: 4/21/25